- Conditions
- Atopic Dermatitis
- Interventions
- Roflumilast Cream 0.05%, Roflumilast Cream 0.15%, Vehicle Cream
- Drug
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 136 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 17
- States / cities
- Scottsdale, Arizona • San Diego, California • Hialeah, Florida + 14 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 841–864
of 1,096
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Asthma
- Interventions
- Nebulized magnesium sulfate
- Drug
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 7 Years to 18 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Actinic Keratoses
- Interventions
- MAL 16.8% cream, MAL Vehicle Cream
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 557 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 59
- States / cities
- Tucson, Arizona • Fort Smith, Arkansas • Encinitas, California + 52 more
- Conditions
- Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
- Interventions
- R89674 (generic name not yet established)
- Drug
- Lead sponsor
- Vistakon Pharmaceuticals
- Industry
- Eligibility
- 3 Years and older
- Enrollment
- 900 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2005
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Bel Air, Maryland • North Andover, Massachusetts + 3 more
- Conditions
- Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement
- Interventions
- OTO-201, Placebo, Sham
- Drug
- Lead sponsor
- Otonomy, Inc.
- Industry
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Obesity, Infant Obesity, Mother-Child Relations, Dietary Habits, Breast Feeding, Physical Activity, Childhood Obesity, Feeding Behavior
- Interventions
- Family Spirit Nurture (FSN), Injury Prevention Education (IPE), Optimized Standard Care (OSC)
- Behavioral · Other
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Other
- Eligibility
- 14 Years to 24 Years · Female only
- Enrollment
- 259 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2023
- U.S. locations
- 3
- States / cities
- Fort Defiance, Arizona • Whiteriver, Arizona • Shiprock, New Mexico
- Conditions
- Knee Osteoarthritis
- Interventions
- Lorecivivint, Placebo
- Drug
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 499 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 44
- States / cities
- Tucson, Arizona • Cerritos, California • La Mesa, California + 35 more
- Conditions
- Acute Pharyngitis, Sore Throat
- Interventions
- flurbiprofen, placebo
- Drug
- Lead sponsor
- Reckitt Benckiser LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 122 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Storrs, Connecticut
- Conditions
- Allergic Conjunctivitis
- Interventions
- Bilastine 0.2%, Bilastine 0.4%, Bilastine 0.6%, Bilastine 0%
- Drug
- Lead sponsor
- Faes Farma, S.A.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Dermatitis
- Interventions
- tacrolimus ointment, placebo ointment
- Drug
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Eligibility
- 17 Years and older
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004
- U.S. locations
- 10
- States / cities
- Washington D.C., District of Columbia • Kansas City, Kansas • Shawnee, Kansas + 7 more
- Conditions
- Nonarteritic Anterior Ischemic Optic Neuropathy
- Interventions
- RPh201 Cohort A, Placebo Cohort A, RPh201 Cohort B, Placebo Cohort B
- Drug · Other
- Lead sponsor
- Regenera Pharma Ltd
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 15
- States / cities
- Palo Alto, California • Pasadena, California • Orange, Connecticut + 12 more
- Conditions
- Drive, Adolescent Behavior, Risk Behavior
- Interventions
- Steering Teens Safe (STS), Driving Feedback Technology.
- Behavioral
- Lead sponsor
- Ginger Yang
- Other
- Eligibility
- 16 Years to 17 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Psoriasis
- Interventions
- CD 2027, Calcitriol Vehicle
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- Fridley, Minnesota • Nashville, Tennessee
- Conditions
- Androgenetic Alopecia
- Interventions
- PP405 0.05% Topical Gel, Topical Vehicle Gel
- Drug
- Lead sponsor
- Pelage Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 78 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 8
- States / cities
- Encinitas, California • Thousand Oaks, California • Indianapolis, Indiana + 5 more
- Conditions
- Myasthenia Gravis
- Interventions
- Rituximab, Placebo
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 21 Years to 90 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Davis, California • Los Angeles, California + 22 more
- Conditions
- Scabies
- Interventions
- spinosad topical suspension, 0.9%, Placebo
- Drug · Other
- Lead sponsor
- ParaPRO LLC
- Industry
- Eligibility
- 4 Years and older
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 7
- States / cities
- Anaheim, California • Long Beach, California • Kissimmee, Florida + 4 more
- Conditions
- Phototoxic Response
- Interventions
- Sunscreen oil with 6% Bemotrizinol, Sunscreen oil vehicle, Dispersion of 6% BEMT in petrolatum, Petrolatum vehicle
- Drug · Other
- Lead sponsor
- dsm-firmenich Switzerland AG
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Piscataway, New Jersey
- Conditions
- Tinea Pedis, Athlete's Foot
- Interventions
- Econazole Nitrate Foam 1%, Vehicle Foam, Econazole Nitrate Cream 1%, Placebo Cream
- Drug · Other
- Lead sponsor
- AmDerma
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 336 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 12
- States / cities
- Fremont, California • Hockessin, Delaware • Boca Raton, Florida + 9 more
- Conditions
- Age-Related Macular Degeneration, Choroidal Neovascularization
- Interventions
- Sirolimus in combination with ranibizumab, Placebo in combination with ranibizumab
- Drug
- Lead sponsor
- Santen Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Phoenix, Arizona
- Conditions
- Oral Lichen Planus
- Interventions
- Pimecrolimus 1% cream
- Drug
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Presbyopia
- Interventions
- Vehicle, Pilocarpine HCl Ophthalmic Solution
- Other · Drug
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 40 Years to 55 Years
- Enrollment
- 323 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 36
- States / cities
- Chandler, Arizona • Scottsdale, Arizona • Beverly Hills, California + 32 more
- Conditions
- Distal, Subungual Onychomycosis
- Interventions
- AN2690, 2.5%, AN2690, 5%, AN2690, 7.5%, Vehicle
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 4
- States / cities
- Albuquerque, New Mexico • Austin, Texas • Bryan, Texas + 1 more
- Conditions
- Acne Vulgaris
- Interventions
- Olumacostat Glasaretil Gel, 5.0%, Olumacostat Glasaretil Gel, Vehicle
- Drug · Other
- Lead sponsor
- Dermira, Inc.
- Industry
- Eligibility
- 9 Years and older
- Enrollment
- 759 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 38
- States / cities
- Phoenix, Arizona • Anaheim, California • Los Angeles, California + 30 more
- Conditions
- Acne Vulgaris
- Interventions
- SB204 4%, Vehicle Gel
- Drug
- Lead sponsor
- Novan, Inc.
- Industry
- Eligibility
- 9 Years to 99 Years
- Enrollment
- 1,330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 55
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 50 more